Low bone mineral content and challenges in interpretation of dual-energy X-ray absorptiometry in children with mucopolysaccharidosis types I, II, and VI

Journal of Clinical Densitometry

Volumn 17, Issue 1, 2014, Pages 200-206

  Polgreen, Lynda E ^a   Thomas, William ^b   Fung, Ellen ^c   Viskochil, David ^d   Stevenson, David A ^d   Steinberger, Julia ^e   Orchard, Paul ^e   Whitley, Chester B ^e   Ensrud, Kristine E ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bone mineral content; Bone mineral density; Mucopolysaccharidoses; Osteoporosis; Skeletal dysplasia

Indexed keywords

BONE MINERAL CONTENT; BONE MINERAL DENSITY; MUCOPOLYSACCHARIDOSES; OSTEOPOROSIS; SKELETAL DYSPLASIA;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; AGE FACTORS; BODY HEIGHT; BONE DENSITY; BONE DEVELOPMENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MUCOPOLYSACCHARIDOSES; OSTEOPOROSIS;

EID: 84895004415     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2013.03.004     Document Type: Article

References (25)

1. Pastores G.M., Arn P., Beck M., et al. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I. Mol Genet Metab 2007, 91(1):37-47.
2. Link B., de Camargo Pinto L.L., Giugliani R., et al. Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey. Orthop Rev (Pavia) 2010, 2(2):e16.
3. Wraith J.E., Scarpa M., Beck M., et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008, 167(3):267-277.
4. Giugliani R., Harmatz P., Wraith J.E. Management guidelines for mucopolysaccharidosis VI. Pediatrics 2007, 120(2):405-418.
5. Schmidt H., Ullrich K., von Lengerke H.J., et al. Radiological findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome). Pediatr Radiol 1987, 17(5):409-414.
6. Aldenhoven M., Sakkers R.J., Boelens J., et al. Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis 2009, 68(11):1659-1665.
7. Monroy M.A., Ross F.P., Teitelbaum S.L., Sands M.S. Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease. Bone 2002, 30(2):352-359.
8. Nuttall J.D., Brumfield L.K., Fazzalari N.L., et al. Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI. Calcif Tissue Int 1999, 65(1):47-52.
9. Russell C., Hendson G., Jevon G., et al. Murine MPS I: insights into the pathogenesis of Hurler syndrome. Clin Genet 1998, 53(5):349-361.
10. Silveri C.P., Kaplan F.S., Fallon M.D., et al. Hurler syndrome with special reference to histologic abnormalities of the growth plate. Clin Orthop Relat Res 1991, 269:305-311.
11. Simonaro C.M., D'Angelo M., Haskins M.E., Schuchman E.H. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res 2005, 57(5 Pt 1):701-707.
12. Zemel B.S., Leonard M.B., Kelly A., et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010, 95(3):1265-1273.
13. Prentice A., Parsons T.J., Cole T.J. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr 1994, 60(6):837-842.
14. Fung E.B., Johnson J.A., Madden J., et al. Bone density assessment in patients with mucopolysaccharidosis: a preliminary report from patients with MPS II and VI. J Pediatr Rehabil Med 2010, 3(1):13-23.
15. Bhatia S., Ramsay N.K., Weisdorf D., et al. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998, 22(1):87-90.
16. Daniels M.W., Wilson D.M., Paguntalan H.G., et al. Bone mineral density in pediatric transplant recipients. Transplantation 2003, 76(4):673-678.
17. Kaste S.C., Shidler T.J., Tong X., et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004, 33(4):435-441.
18. Assessment of skeletal maturity and prediction of adult height (TW2 method) 1975, Academic Press, New York. J.M. Tanner (Ed.).
19. Greulich W.W., Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist 1959, Stanford University Press, Stanford, CA. 2nd ed.
20. Steinberger J., Sinaiko A.R., Kelly A.S., et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. J Pediatr 2012, 160(3):494-499.
21. Polgreen L.E., Petryk A., Dietz A.C., et al. Modifiable risk factors associated with bone deficits in childhood cancer survivors. BMC Pediatr 2012, 12:40.
22. Baim S., Leonard M.B., Bianchi M.L., et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 2008, 11(1):6-21.
23. Wren T.A., Liu X., Pitukcheewanont P., Gilsanz V. Bone acquisition in healthy children and adolescents: comparisons of dual-energy x-ray absorptiometry and computed tomography measures. J Clin Endocrinol Metab 2005, 90(4):1925-1928.
24. Lanes R., Gunczler P., Esaa S., Weisinger J.R. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. Clin Endocrinol (Oxf) 2002, 57(6):725-730.
25. Hogler W., Briody J., Moore B., et al. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone 2005, 37(5):642-650.